Medexus Pharmaceuticals Inc.

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, IPSEY has a market cap of 65B. Regarding current trading prices, MEDXF is priced at $2.95, while IPSEY trades at $49.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas IPSEY's P/E ratio is 31.71. In terms of profitability, MEDXF's ROE is -0.01%, compared to IPSEY's ROE of +0.10%. Regarding short-term risk, MEDXF is more volatile compared to IPSEY. This indicates potentially higher risk in terms of short-term price fluctuations for MEDXF.Check IPSEY's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, MKKGY has a market cap of 59.7B. Regarding current trading prices, MEDXF is priced at $2.95, while MKKGY trades at $27.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas MKKGY's P/E ratio is 19.60. In terms of profitability, MEDXF's ROE is -0.01%, compared to MKKGY's ROE of +0.09%. Regarding short-term risk, MEDXF is more volatile compared to MKKGY. This indicates potentially higher risk in terms of short-term price fluctuations for MEDXF.Check MKKGY's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, MKGAF has a market cap of 58.2B. Regarding current trading prices, MEDXF is priced at $2.95, while MKGAF trades at $133.78.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas MKGAF's P/E ratio is 19.08. In terms of profitability, MEDXF's ROE is -0.01%, compared to MKGAF's ROE of +0.09%. Regarding short-term risk, MEDXF is less volatile compared to MKGAF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check MKGAF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, TKPHF has a market cap of 54.5B. Regarding current trading prices, MEDXF is priced at $2.95, while TKPHF trades at $34.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas TKPHF's P/E ratio is 76.71. In terms of profitability, MEDXF's ROE is -0.01%, compared to TKPHF's ROE of +0.02%. Regarding short-term risk, MEDXF is more volatile compared to TKPHF. This indicates potentially higher risk in terms of short-term price fluctuations for MEDXF.Check TKPHF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, HLNCF has a market cap of 43.2B. Regarding current trading prices, MEDXF is priced at $2.95, while HLNCF trades at $4.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas HLNCF's P/E ratio is 19.40. In terms of profitability, MEDXF's ROE is -0.01%, compared to HLNCF's ROE of +0.06%. Regarding short-term risk, MEDXF is more volatile compared to HLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for MEDXF.Check HLNCF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, SDZNY has a market cap of 37.4B. Regarding current trading prices, MEDXF is priced at $2.95, while SDZNY trades at $86.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas SDZNY's P/E ratio is 40.40. In terms of profitability, MEDXF's ROE is -0.01%, compared to SDZNY's ROE of +0.08%. Regarding short-term risk, MEDXF is more volatile compared to SDZNY. This indicates potentially higher risk in terms of short-term price fluctuations for MEDXF.Check SDZNY's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, TEVJF has a market cap of 33B. Regarding current trading prices, MEDXF is priced at $2.95, while TEVJF trades at $28.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas TEVJF's P/E ratio is 23.44. In terms of profitability, MEDXF's ROE is -0.01%, compared to TEVJF's ROE of +0.20%. Regarding short-term risk, MEDXF is more volatile compared to TEVJF. This indicates potentially higher risk in terms of short-term price fluctuations for MEDXF.Check TEVJF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, SGIOF has a market cap of 18.6B. Regarding current trading prices, MEDXF is priced at $2.95, while SGIOF trades at $21.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas SGIOF's P/E ratio is 17.20. In terms of profitability, MEDXF's ROE is -0.01%, compared to SGIOF's ROE of +0.14%. Regarding short-term risk, MEDXF is less volatile compared to SGIOF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check SGIOF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, TAIPY has a market cap of 18.1B. Regarding current trading prices, MEDXF is priced at $2.95, while TAIPY trades at $14.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas TAIPY's P/E ratio is 82.35. In terms of profitability, MEDXF's ROE is -0.01%, compared to TAIPY's ROE of +0.02%. Regarding short-term risk, MEDXF is less volatile compared to TAIPY. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check TAIPY's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, SGIOY has a market cap of 17.9B. Regarding current trading prices, MEDXF is priced at $2.95, while SGIOY trades at $10.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas SGIOY's P/E ratio is 16.68. In terms of profitability, MEDXF's ROE is -0.01%, compared to SGIOY's ROE of +0.14%. Regarding short-term risk, MEDXF is more volatile compared to SGIOY. This indicates potentially higher risk in terms of short-term price fluctuations for MEDXF.Check SGIOY's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, MEDXF is priced at $2.95, while ESALY trades at $61.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas ESALY's P/E ratio is 20.54. In terms of profitability, MEDXF's ROE is -0.01%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, MEDXF is less volatile compared to ESALY. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check ESALY's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, BIOVF has a market cap of 13.8B. Regarding current trading prices, MEDXF is priced at $2.95, while BIOVF trades at $39.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas BIOVF's P/E ratio is 265.80. In terms of profitability, MEDXF's ROE is -0.01%, compared to BIOVF's ROE of +0.01%. Regarding short-term risk, MEDXF is less volatile compared to BIOVF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check BIOVF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, IPSEF has a market cap of 9.4B. Regarding current trading prices, MEDXF is priced at $2.95, while IPSEF trades at $113.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas IPSEF's P/E ratio is 18.07. In terms of profitability, MEDXF's ROE is -0.01%, compared to IPSEF's ROE of +0.12%. Regarding short-term risk, MEDXF is less volatile compared to IPSEF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check IPSEF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, ESAIY has a market cap of 8.8B. Regarding current trading prices, MEDXF is priced at $2.95, while ESAIY trades at $7.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas ESAIY's P/E ratio is 27.54. In terms of profitability, MEDXF's ROE is -0.01%, compared to ESAIY's ROE of +0.05%. Regarding short-term risk, MEDXF is more volatile compared to ESAIY. This indicates potentially higher risk in terms of short-term price fluctuations for MEDXF.Check ESAIY's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, ESALF has a market cap of 8.5B. Regarding current trading prices, MEDXF is priced at $2.95, while ESALF trades at $30.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas ESALF's P/E ratio is 27.27. In terms of profitability, MEDXF's ROE is -0.01%, compared to ESALF's ROE of +0.05%. Regarding short-term risk, MEDXF is less volatile compared to ESALF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check ESALF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, SFOSF has a market cap of 7.1B. Regarding current trading prices, MEDXF is priced at $2.95, while SFOSF trades at $2.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas SFOSF's P/E ratio is 14.21. In terms of profitability, MEDXF's ROE is -0.01%, compared to SFOSF's ROE of +0.09%. Regarding short-term risk, MEDXF is less volatile compared to SFOSF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check SFOSF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, GZPHF has a market cap of 6.2B. Regarding current trading prices, MEDXF is priced at $2.95, while GZPHF trades at $2.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas GZPHF's P/E ratio is 9.00. In terms of profitability, MEDXF's ROE is -0.01%, compared to GZPHF's ROE of +0.08%. Regarding short-term risk, MEDXF is more volatile compared to GZPHF. This indicates potentially higher risk in terms of short-term price fluctuations for MEDXF.Check GZPHF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, LVZPF has a market cap of 6.1B. Regarding current trading prices, MEDXF is priced at $2.95, while LVZPF trades at $5.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas LVZPF's P/E ratio is 15.35. In terms of profitability, MEDXF's ROE is -0.01%, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, MEDXF is less volatile compared to LVZPF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check LVZPF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, HLUBF has a market cap of 4.8B. Regarding current trading prices, MEDXF is priced at $2.95, while HLUBF trades at $4.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas HLUBF's P/E ratio is 9.64. In terms of profitability, MEDXF's ROE is -0.01%, compared to HLUBF's ROE of +0.13%. Regarding short-term risk, MEDXF is less volatile compared to HLUBF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check HLUBF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, HLBBF has a market cap of 4.7B. Regarding current trading prices, MEDXF is priced at $2.95, while HLBBF trades at $5.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas HLBBF's P/E ratio is 11.57. In terms of profitability, MEDXF's ROE is -0.01%, compared to HLBBF's ROE of +0.13%. Regarding short-term risk, MEDXF is more volatile compared to HLBBF. This indicates potentially higher risk in terms of short-term price fluctuations for MEDXF.Check HLBBF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, SMDPY has a market cap of 4.7B. Regarding current trading prices, MEDXF is priced at $2.95, while SMDPY trades at $11.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas SMDPY's P/E ratio is 4.80. In terms of profitability, MEDXF's ROE is -0.01%, compared to SMDPY's ROE of +0.49%. Regarding short-term risk, MEDXF is less volatile compared to SMDPY. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check SMDPY's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, DNPUF has a market cap of 4.4B. Regarding current trading prices, MEDXF is priced at $2.95, while DNPUF trades at $11.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas DNPUF's P/E ratio is 4.53. In terms of profitability, MEDXF's ROE is -0.01%, compared to DNPUF's ROE of +0.49%. Regarding short-term risk, MEDXF is less volatile compared to DNPUF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check DNPUF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, SGFEF has a market cap of 4.4B. Regarding current trading prices, MEDXF is priced at $2.95, while SGFEF trades at $100.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas SGFEF's P/E ratio is 20.62. In terms of profitability, MEDXF's ROE is -0.01%, compared to SGFEF's ROE of +0.16%. Regarding short-term risk, MEDXF is less volatile compared to SGFEF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check SGFEF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, HKMPY has a market cap of 4B. Regarding current trading prices, MEDXF is priced at $2.95, while HKMPY trades at $36.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas HKMPY's P/E ratio is 10.05. In terms of profitability, MEDXF's ROE is -0.01%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, MEDXF is more volatile compared to HKMPY. This indicates potentially higher risk in terms of short-term price fluctuations for MEDXF.Check HKMPY's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, HKMPF has a market cap of 3.9B. Regarding current trading prices, MEDXF is priced at $2.95, while HKMPF trades at $18.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas HKMPF's P/E ratio is 9.94. In terms of profitability, MEDXF's ROE is -0.01%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, MEDXF is more volatile compared to HKMPF. This indicates potentially higher risk in terms of short-term price fluctuations for MEDXF.Check HKMPF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, APNHF has a market cap of 3.9B. Regarding current trading prices, MEDXF is priced at $2.95, while APNHF trades at $8.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas APNHF's P/E ratio is -34.76. In terms of profitability, MEDXF's ROE is -0.01%, compared to APNHF's ROE of -0.02%. Regarding short-term risk, MEDXF is less volatile compared to APNHF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check APNHF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, APNHY has a market cap of 3.6B. Regarding current trading prices, MEDXF is priced at $2.95, while APNHY trades at $8.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas APNHY's P/E ratio is -32.00. In terms of profitability, MEDXF's ROE is -0.01%, compared to APNHY's ROE of -0.02%. Regarding short-term risk, MEDXF is more volatile compared to APNHY. This indicates potentially higher risk in terms of short-term price fluctuations for MEDXF.Check APNHY's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, HYPMY has a market cap of 3.3B. Regarding current trading prices, MEDXF is priced at $2.95, while HYPMY trades at $4.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas HYPMY's P/E ratio is 13.10. In terms of profitability, MEDXF's ROE is -0.01%, compared to HYPMY's ROE of +0.10%. Regarding short-term risk, MEDXF is more volatile compared to HYPMY. This indicates potentially higher risk in terms of short-term price fluctuations for MEDXF.Check HYPMY's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, LBTSF has a market cap of 3.3B. Regarding current trading prices, MEDXF is priced at $2.95, while LBTSF trades at $15.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas LBTSF's P/E ratio is 59.04. In terms of profitability, MEDXF's ROE is -0.01%, compared to LBTSF's ROE of +0.04%. Regarding short-term risk, MEDXF is more volatile compared to LBTSF. This indicates potentially higher risk in terms of short-term price fluctuations for MEDXF.Check LBTSF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, CHSYF has a market cap of 3.3B. Regarding current trading prices, MEDXF is priced at $2.95, while CHSYF trades at $1.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas CHSYF's P/E ratio is 13.50. In terms of profitability, MEDXF's ROE is -0.01%, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, MEDXF is less volatile compared to CHSYF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check CHSYF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, MEDXF is priced at $2.95, while INVVY trades at $21.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas INVVY's P/E ratio is -62.42. In terms of profitability, MEDXF's ROE is -0.01%, compared to INVVY's ROE of -0.99%. Regarding short-term risk, MEDXF is more volatile compared to INVVY. This indicates potentially higher risk in terms of short-term price fluctuations for MEDXF.Check INVVY's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, MEDXF is priced at $2.95, while IZQVF trades at $20.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, MEDXF's ROE is -0.01%, compared to IZQVF's ROE of -0.99%. Regarding short-term risk, MEDXF is more volatile compared to IZQVF. This indicates potentially higher risk in terms of short-term price fluctuations for MEDXF.Check IZQVF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, ULIHF has a market cap of 2.6B. Regarding current trading prices, MEDXF is priced at $2.95, while ULIHF trades at $1.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas ULIHF's P/E ratio is 8.13. In terms of profitability, MEDXF's ROE is -0.01%, compared to ULIHF's ROE of +0.13%. Regarding short-term risk, MEDXF is more volatile compared to ULIHF. This indicates potentially higher risk in terms of short-term price fluctuations for MEDXF.Check ULIHF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, HMDCF has a market cap of 2.4B. Regarding current trading prices, MEDXF is priced at $2.95, while HMDCF trades at $2.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas HMDCF's P/E ratio is 5.32. In terms of profitability, MEDXF's ROE is -0.01%, compared to HMDCF's ROE of +0.41%. Regarding short-term risk, MEDXF is less volatile compared to HMDCF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check HMDCF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, DMPHF has a market cap of 2.1B. Regarding current trading prices, MEDXF is priced at $2.95, while DMPHF trades at $39.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas DMPHF's P/E ratio is 17.90. In terms of profitability, MEDXF's ROE is -0.01%, compared to DMPHF's ROE of +0.20%. Regarding short-term risk, MEDXF is less volatile compared to DMPHF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check DMPHF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, NPNKF has a market cap of 2.1B. Regarding current trading prices, MEDXF is priced at $2.95, while NPNKF trades at $31.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas NPNKF's P/E ratio is 10.50. In terms of profitability, MEDXF's ROE is -0.01%, compared to NPNKF's ROE of +0.11%. Regarding short-term risk, MEDXF is less volatile compared to NPNKF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check NPNKF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, HTSUF has a market cap of 2B. Regarding current trading prices, MEDXF is priced at $2.95, while HTSUF trades at $29.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas HTSUF's P/E ratio is 16.76. In terms of profitability, MEDXF's ROE is -0.01%, compared to HTSUF's ROE of +0.07%. Regarding short-term risk, MEDXF is more volatile compared to HTSUF. This indicates potentially higher risk in terms of short-term price fluctuations for MEDXF.Check HTSUF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, NPPNY has a market cap of 2B. Regarding current trading prices, MEDXF is priced at $2.95, while NPPNY trades at $7.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas NPPNY's P/E ratio is 9.87. In terms of profitability, MEDXF's ROE is -0.01%, compared to NPPNY's ROE of +0.12%. Regarding short-term risk, MEDXF is less volatile compared to NPPNY. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check NPPNY's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, ARSUF has a market cap of 1.9B. Regarding current trading prices, MEDXF is priced at $2.95, while ARSUF trades at $26.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas ARSUF's P/E ratio is 18.30. In terms of profitability, MEDXF's ROE is -0.01%, compared to ARSUF's ROE of +0.17%. Regarding short-term risk, MEDXF is more volatile compared to ARSUF. This indicates potentially higher risk in terms of short-term price fluctuations for MEDXF.Check ARSUF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, DUTV has a market cap of 1.9B. Regarding current trading prices, MEDXF is priced at $2.95, while DUTV trades at $0.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas DUTV's P/E ratio is N/A. In terms of profitability, MEDXF's ROE is -0.01%, compared to DUTV's ROE of -0.04%. Regarding short-term risk, MEDXF is less volatile compared to DUTV. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check DUTV's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, CURLF has a market cap of 1.9B. Regarding current trading prices, MEDXF is priced at $2.95, while CURLF trades at $2.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas CURLF's P/E ratio is -7.56. In terms of profitability, MEDXF's ROE is -0.01%, compared to CURLF's ROE of -0.29%. Regarding short-term risk, MEDXF is less volatile compared to CURLF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check CURLF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, TSMRF has a market cap of 1.7B. Regarding current trading prices, MEDXF is priced at $2.95, while TSMRF trades at $23.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas TSMRF's P/E ratio is 10.04. In terms of profitability, MEDXF's ROE is -0.01%, compared to TSMRF's ROE of +0.10%. Regarding short-term risk, MEDXF is less volatile compared to TSMRF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check TSMRF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, SHPHF has a market cap of 1.7B. Regarding current trading prices, MEDXF is priced at $2.95, while SHPHF trades at $0.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas SHPHF's P/E ratio is -6.22. In terms of profitability, MEDXF's ROE is -0.01%, compared to SHPHF's ROE of +0.03%. Regarding short-term risk, MEDXF is more volatile compared to SHPHF. This indicates potentially higher risk in terms of short-term price fluctuations for MEDXF.Check SHPHF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, MEDXF is priced at $2.95, while MITPF trades at $23.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas MITPF's P/E ratio is -10.81. In terms of profitability, MEDXF's ROE is -0.01%, compared to MITPF's ROE of +4.99%. Regarding short-term risk, MEDXF is less volatile compared to MITPF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check MITPF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, GTBIF has a market cap of 1.6B. Regarding current trading prices, MEDXF is priced at $2.95, while GTBIF trades at $6.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas GTBIF's P/E ratio is 13.89. In terms of profitability, MEDXF's ROE is -0.01%, compared to GTBIF's ROE of +0.06%. Regarding short-term risk, MEDXF is less volatile compared to GTBIF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check GTBIF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, MEDXF is priced at $2.95, while KARBF trades at $5.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas KARBF's P/E ratio is 262.50. In terms of profitability, MEDXF's ROE is -0.01%, compared to KARBF's ROE of N/A. Regarding short-term risk, MEDXF is more volatile compared to KARBF. This indicates potentially higher risk in terms of short-term price fluctuations for MEDXF.Check KARBF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, CHIZF has a market cap of 1.4B. Regarding current trading prices, MEDXF is priced at $2.95, while CHIZF trades at $0.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas CHIZF's P/E ratio is -27.34. In terms of profitability, MEDXF's ROE is -0.01%, compared to CHIZF's ROE of -0.01%. Regarding short-term risk, MEDXF is more volatile compared to CHIZF. This indicates potentially higher risk in terms of short-term price fluctuations for MEDXF.Check CHIZF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, CASBF has a market cap of 1.3B. Regarding current trading prices, MEDXF is priced at $2.95, while CASBF trades at $3.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas CASBF's P/E ratio is -38.60. In terms of profitability, MEDXF's ROE is -0.01%, compared to CASBF's ROE of +0.01%. Regarding short-term risk, MEDXF is less volatile compared to CASBF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check CASBF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, SWGHF has a market cap of 1.3B. Regarding current trading prices, MEDXF is priced at $2.95, while SWGHF trades at $11.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas SWGHF's P/E ratio is 15.57. In terms of profitability, MEDXF's ROE is -0.01%, compared to SWGHF's ROE of +0.05%. Regarding short-term risk, MEDXF is more volatile compared to SWGHF. This indicates potentially higher risk in terms of short-term price fluctuations for MEDXF.Check SWGHF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, TCNNF has a market cap of 1.2B. Regarding current trading prices, MEDXF is priced at $2.95, while TCNNF trades at $6.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas TCNNF's P/E ratio is -11.03. In terms of profitability, MEDXF's ROE is -0.01%, compared to TCNNF's ROE of -0.10%. Regarding short-term risk, MEDXF is less volatile compared to TCNNF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check TCNNF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, LJUIF has a market cap of 1.2B. Regarding current trading prices, MEDXF is priced at $2.95, while LJUIF trades at $0.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas LJUIF's P/E ratio is 13.42. In terms of profitability, MEDXF's ROE is -0.01%, compared to LJUIF's ROE of +0.06%. Regarding short-term risk, MEDXF is less volatile compared to LJUIF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check LJUIF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, BIOGY has a market cap of 1.1B. Regarding current trading prices, MEDXF is priced at $2.95, while BIOGY trades at $11.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas BIOGY's P/E ratio is 31.43. In terms of profitability, MEDXF's ROE is -0.01%, compared to BIOGY's ROE of +0.24%. Regarding short-term risk, MEDXF is more volatile compared to BIOGY. This indicates potentially higher risk in terms of short-term price fluctuations for MEDXF.Check BIOGY's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, KSPHF has a market cap of 1.1B. Regarding current trading prices, MEDXF is priced at $2.95, while KSPHF trades at $25.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas KSPHF's P/E ratio is 11.93. In terms of profitability, MEDXF's ROE is -0.01%, compared to KSPHF's ROE of +0.07%. Regarding short-term risk, MEDXF is less volatile compared to KSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check KSPHF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, GNMLF has a market cap of 1.1B. Regarding current trading prices, MEDXF is priced at $2.95, while GNMLF trades at $1.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas GNMLF's P/E ratio is 12.00. In terms of profitability, MEDXF's ROE is -0.01%, compared to GNMLF's ROE of +0.11%. Regarding short-term risk, MEDXF is less volatile compared to GNMLF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check GNMLF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, KKPCF has a market cap of 984.6M. Regarding current trading prices, MEDXF is priced at $2.95, while KKPCF trades at $26.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas KKPCF's P/E ratio is 288.89. In terms of profitability, MEDXF's ROE is -0.01%, compared to KKPCF's ROE of -0.03%. Regarding short-term risk, MEDXF is less volatile compared to KKPCF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check KKPCF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, EVOTF has a market cap of 930.6M. Regarding current trading prices, MEDXF is priced at $2.95, while EVOTF trades at $5.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas EVOTF's P/E ratio is -7.71. In terms of profitability, MEDXF's ROE is -0.01%, compared to EVOTF's ROE of -0.12%. Regarding short-term risk, MEDXF is less volatile compared to EVOTF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check EVOTF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, TWAPF has a market cap of 828.5M. Regarding current trading prices, MEDXF is priced at $2.95, while TWAPF trades at $16.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas TWAPF's P/E ratio is 6.28. In terms of profitability, MEDXF's ROE is -0.01%, compared to TWAPF's ROE of +0.12%. Regarding short-term risk, MEDXF is less volatile compared to TWAPF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check TWAPF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, NIKA has a market cap of 785M. Regarding current trading prices, MEDXF is priced at $2.95, while NIKA trades at $0.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas NIKA's P/E ratio is N/A. In terms of profitability, MEDXF's ROE is -0.01%, compared to NIKA's ROE of +0.29%. Regarding short-term risk, MEDXF is more volatile compared to NIKA. This indicates potentially higher risk in terms of short-term price fluctuations for MEDXF.Check NIKA's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, CSWYF has a market cap of 758.4M. Regarding current trading prices, MEDXF is priced at $2.95, while CSWYF trades at $1.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas CSWYF's P/E ratio is 4.78. In terms of profitability, MEDXF's ROE is -0.01%, compared to CSWYF's ROE of +0.20%. Regarding short-term risk, MEDXF is less volatile compared to CSWYF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check CSWYF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, TRXPF has a market cap of 690.7M. Regarding current trading prices, MEDXF is priced at $2.95, while TRXPF trades at $24.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, MEDXF's ROE is -0.01%, compared to TRXPF's ROE of +0.03%. Regarding short-term risk, MEDXF is more volatile compared to TRXPF. This indicates potentially higher risk in terms of short-term price fluctuations for MEDXF.Check TRXPF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, SHEZF has a market cap of 689M. Regarding current trading prices, MEDXF is priced at $2.95, while SHEZF trades at $0.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas SHEZF's P/E ratio is -23.48. In terms of profitability, MEDXF's ROE is -0.01%, compared to SHEZF's ROE of +0.01%. Regarding short-term risk, MEDXF is less volatile compared to SHEZF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check SHEZF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, YIHCF has a market cap of 643.1M. Regarding current trading prices, MEDXF is priced at $2.95, while YIHCF trades at $0.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, MEDXF's ROE is -0.01%, compared to YIHCF's ROE of +0.06%. Regarding short-term risk, MEDXF is more volatile compared to YIHCF. This indicates potentially higher risk in terms of short-term price fluctuations for MEDXF.Check YIHCF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, GLASF has a market cap of 626M. Regarding current trading prices, MEDXF is priced at $2.95, while GLASF trades at $8.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas GLASF's P/E ratio is -14.70. In terms of profitability, MEDXF's ROE is -0.01%, compared to GLASF's ROE of -0.23%. Regarding short-term risk, MEDXF is more volatile compared to GLASF. This indicates potentially higher risk in terms of short-term price fluctuations for MEDXF.Check GLASF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, AIHLF has a market cap of 624.3M. Regarding current trading prices, MEDXF is priced at $2.95, while AIHLF trades at $3.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas AIHLF's P/E ratio is 10.94. In terms of profitability, MEDXF's ROE is -0.01%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, MEDXF is more volatile compared to AIHLF. This indicates potentially higher risk in terms of short-term price fluctuations for MEDXF.Check AIHLF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, MEDXF is priced at $2.95, while TRSSF trades at $1.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, MEDXF's ROE is -0.01%, compared to TRSSF's ROE of -0.68%. Regarding short-term risk, MEDXF is less volatile compared to TRSSF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check TRSSF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, AGYTF has a market cap of 554.6M. Regarding current trading prices, MEDXF is priced at $2.95, while AGYTF trades at $0.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas AGYTF's P/E ratio is -11.00. In terms of profitability, MEDXF's ROE is -0.01%, compared to AGYTF's ROE of +2.84%. Regarding short-term risk, MEDXF is more volatile compared to AGYTF. This indicates potentially higher risk in terms of short-term price fluctuations for MEDXF.Check AGYTF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, PKBFF has a market cap of 544.7M. Regarding current trading prices, MEDXF is priced at $2.95, while PKBFF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas PKBFF's P/E ratio is N/A. In terms of profitability, MEDXF's ROE is -0.01%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, MEDXF is more volatile compared to PKBFF. This indicates potentially higher risk in terms of short-term price fluctuations for MEDXF.Check PKBFF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, KHTRF has a market cap of 538.6M. Regarding current trading prices, MEDXF is priced at $2.95, while KHTRF trades at $5.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas KHTRF's P/E ratio is -137.35. In terms of profitability, MEDXF's ROE is -0.01%, compared to KHTRF's ROE of -0.01%. Regarding short-term risk, MEDXF is more volatile compared to KHTRF. This indicates potentially higher risk in terms of short-term price fluctuations for MEDXF.Check KHTRF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, MEDXF is priced at $2.95, while CCHWF trades at $0.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, MEDXF's ROE is -0.01%, compared to CCHWF's ROE of +0.42%. Regarding short-term risk, MEDXF is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check CCHWF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, BOIRF has a market cap of 520.9M. Regarding current trading prices, MEDXF is priced at $2.95, while BOIRF trades at $30.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas BOIRF's P/E ratio is 22.73. In terms of profitability, MEDXF's ROE is -0.01%, compared to BOIRF's ROE of +0.05%. Regarding short-term risk, MEDXF is more volatile compared to BOIRF. This indicates potentially higher risk in terms of short-term price fluctuations for MEDXF.Check BOIRF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, VRNOF has a market cap of 470.4M. Regarding current trading prices, MEDXF is priced at $2.95, while VRNOF trades at $1.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas VRNOF's P/E ratio is -1.31. In terms of profitability, MEDXF's ROE is -0.01%, compared to VRNOF's ROE of -0.30%. Regarding short-term risk, MEDXF is less volatile compared to VRNOF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check VRNOF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, HUMDF has a market cap of 466.1M. Regarding current trading prices, MEDXF is priced at $2.95, while HUMDF trades at $0.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas HUMDF's P/E ratio is 2.95. In terms of profitability, MEDXF's ROE is -0.01%, compared to HUMDF's ROE of +1.07%. Regarding short-term risk, MEDXF is less volatile compared to HUMDF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check HUMDF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, MEDXF is priced at $2.95, while PEXXF trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, MEDXF's ROE is -0.01%, compared to PEXXF's ROE of N/A. Regarding short-term risk, MEDXF is more volatile compared to PEXXF. This indicates potentially higher risk in terms of short-term price fluctuations for MEDXF.Check PEXXF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, ELTP has a market cap of 409.3M. Regarding current trading prices, MEDXF is priced at $2.95, while ELTP trades at $0.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas ELTP's P/E ratio is 9.50. In terms of profitability, MEDXF's ROE is -0.01%, compared to ELTP's ROE of +0.71%. Regarding short-term risk, MEDXF is less volatile compared to ELTP. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check ELTP's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, SWDCF has a market cap of 399.6M. Regarding current trading prices, MEDXF is priced at $2.95, while SWDCF trades at $2.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas SWDCF's P/E ratio is 62.50. In terms of profitability, MEDXF's ROE is -0.01%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, MEDXF is less volatile compared to SWDCF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check SWDCF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, CPHRF has a market cap of 359.5M. Regarding current trading prices, MEDXF is priced at $2.95, while CPHRF trades at $14.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas CPHRF's P/E ratio is 13.48. In terms of profitability, MEDXF's ROE is -0.01%, compared to CPHRF's ROE of +0.24%. Regarding short-term risk, MEDXF is more volatile compared to CPHRF. This indicates potentially higher risk in terms of short-term price fluctuations for MEDXF.Check CPHRF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, CRLBF has a market cap of 314.8M. Regarding current trading prices, MEDXF is priced at $2.95, while CRLBF trades at $0.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas CRLBF's P/E ratio is -2.41. In terms of profitability, MEDXF's ROE is -0.01%, compared to CRLBF's ROE of -0.33%. Regarding short-term risk, MEDXF is less volatile compared to CRLBF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check CRLBF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, PROCF has a market cap of 230.4M. Regarding current trading prices, MEDXF is priced at $2.95, while PROCF trades at $0.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas PROCF's P/E ratio is -0.15. In terms of profitability, MEDXF's ROE is -0.01%, compared to PROCF's ROE of -2.24%. Regarding short-term risk, MEDXF is less volatile compared to PROCF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check PROCF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, BHCCF has a market cap of 225.1M. Regarding current trading prices, MEDXF is priced at $2.95, while BHCCF trades at $0.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, MEDXF's ROE is -0.01%, compared to BHCCF's ROE of +0.29%. Regarding short-term risk, MEDXF is less volatile compared to BHCCF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check BHCCF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, MEDXF is priced at $2.95, while PLNHF trades at $0.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, MEDXF's ROE is -0.01%, compared to PLNHF's ROE of +659479.06%. Regarding short-term risk, MEDXF is less volatile compared to PLNHF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check PLNHF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, PHCUF has a market cap of 188.1M. Regarding current trading prices, MEDXF is priced at $2.95, while PHCUF trades at $7.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas PHCUF's P/E ratio is -707.00. In terms of profitability, MEDXF's ROE is -0.01%, compared to PHCUF's ROE of -0.00%. Regarding short-term risk, MEDXF is more volatile compared to PHCUF. This indicates potentially higher risk in terms of short-term price fluctuations for MEDXF.Check PHCUF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, CBWTF has a market cap of 135.4M. Regarding current trading prices, MEDXF is priced at $2.95, while CBWTF trades at $0.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas CBWTF's P/E ratio is 4.83. In terms of profitability, MEDXF's ROE is -0.01%, compared to CBWTF's ROE of +0.23%. Regarding short-term risk, MEDXF is less volatile compared to CBWTF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check CBWTF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, SHIEF has a market cap of 134.6M. Regarding current trading prices, MEDXF is priced at $2.95, while SHIEF trades at $0.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas SHIEF's P/E ratio is -6.30. In terms of profitability, MEDXF's ROE is -0.01%, compared to SHIEF's ROE of +1.01%. Regarding short-term risk, MEDXF is less volatile compared to SHIEF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check SHIEF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, LOVFF has a market cap of 133.5M. Regarding current trading prices, MEDXF is priced at $2.95, while LOVFF trades at $1.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas LOVFF's P/E ratio is 15.49. In terms of profitability, MEDXF's ROE is -0.01%, compared to LOVFF's ROE of +0.12%. Regarding short-term risk, MEDXF is less volatile compared to LOVFF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check LOVFF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, MEDXF is priced at $2.95, while COPHF trades at $0.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas COPHF's P/E ratio is -0.02. In terms of profitability, MEDXF's ROE is -0.01%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, MEDXF is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check COPHF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, BIOYF has a market cap of 125M. Regarding current trading prices, MEDXF is priced at $2.95, while BIOYF trades at $10.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas BIOYF's P/E ratio is 19.07. In terms of profitability, MEDXF's ROE is -0.01%, compared to BIOYF's ROE of +0.23%. Regarding short-term risk, MEDXF is more volatile compared to BIOYF. This indicates potentially higher risk in terms of short-term price fluctuations for MEDXF.Check BIOYF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, NWPN has a market cap of 123.7M. Regarding current trading prices, MEDXF is priced at $2.95, while NWPN trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas NWPN's P/E ratio is -0.04. In terms of profitability, MEDXF's ROE is -0.01%, compared to NWPN's ROE of +0.13%. Regarding short-term risk, MEDXF is less volatile compared to NWPN. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check NWPN's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, LPCUF has a market cap of 112.1M. Regarding current trading prices, MEDXF is priced at $2.95, while LPCUF trades at $0.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas LPCUF's P/E ratio is 9.51. In terms of profitability, MEDXF's ROE is -0.01%, compared to LPCUF's ROE of +0.06%. Regarding short-term risk, MEDXF is less volatile compared to LPCUF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check LPCUF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, CNVCF has a market cap of 109.2M. Regarding current trading prices, MEDXF is priced at $2.95, while CNVCF trades at $6.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, MEDXF's ROE is -0.01%, compared to CNVCF's ROE of +1.21%. Regarding short-term risk, MEDXF is more volatile compared to CNVCF. This indicates potentially higher risk in terms of short-term price fluctuations for MEDXF.Check CNVCF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, JUSHF has a market cap of 102.7M. Regarding current trading prices, MEDXF is priced at $2.95, while JUSHF trades at $0.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas JUSHF's P/E ratio is -1.47. In terms of profitability, MEDXF's ROE is -0.01%, compared to JUSHF's ROE of +0.76%. Regarding short-term risk, MEDXF is less volatile compared to JUSHF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check JUSHF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, HLTRF has a market cap of 100.4M. Regarding current trading prices, MEDXF is priced at $2.95, while HLTRF trades at $3.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas HLTRF's P/E ratio is -8.23. In terms of profitability, MEDXF's ROE is -0.01%, compared to HLTRF's ROE of -0.19%. Regarding short-term risk, MEDXF is more volatile compared to HLTRF. This indicates potentially higher risk in terms of short-term price fluctuations for MEDXF.Check HLTRF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, CWBHF has a market cap of 100.3M. Regarding current trading prices, MEDXF is priced at $2.95, while CWBHF trades at $0.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas CWBHF's P/E ratio is -3.31. In terms of profitability, MEDXF's ROE is -0.01%, compared to CWBHF's ROE of -2.75%. Regarding short-term risk, MEDXF is less volatile compared to CWBHF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check CWBHF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, ORXOY has a market cap of 97.2M. Regarding current trading prices, MEDXF is priced at $2.95, while ORXOY trades at $2.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas ORXOY's P/E ratio is -2.24. In terms of profitability, MEDXF's ROE is -0.01%, compared to ORXOY's ROE of +5.65%. Regarding short-term risk, MEDXF is more volatile compared to ORXOY. This indicates potentially higher risk in terms of short-term price fluctuations for MEDXF.Check ORXOY's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, AAWH has a market cap of 95M. Regarding current trading prices, MEDXF is priced at $2.95, while AAWH trades at $0.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas AAWH's P/E ratio is -0.77. In terms of profitability, MEDXF's ROE is -0.01%, compared to AAWH's ROE of -14.10%. Regarding short-term risk, MEDXF is less volatile compared to AAWH. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check AAWH's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, ABSCF has a market cap of 90.7M. Regarding current trading prices, MEDXF is priced at $2.95, while ABSCF trades at $1.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas ABSCF's P/E ratio is -8.06. In terms of profitability, MEDXF's ROE is -0.01%, compared to ABSCF's ROE of +0.33%. Regarding short-term risk, MEDXF is less volatile compared to ABSCF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check ABSCF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, GRUSF has a market cap of 80.5M. Regarding current trading prices, MEDXF is priced at $2.95, while GRUSF trades at $0.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas GRUSF's P/E ratio is 32.21. In terms of profitability, MEDXF's ROE is -0.01%, compared to GRUSF's ROE of +0.00%. Regarding short-term risk, MEDXF is less volatile compared to GRUSF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check GRUSF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, ORXOF has a market cap of 79.4M. Regarding current trading prices, MEDXF is priced at $2.95, while ORXOF trades at $2.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas ORXOF's P/E ratio is -1.86. In terms of profitability, MEDXF's ROE is -0.01%, compared to ORXOF's ROE of +5.65%. Regarding short-term risk, MEDXF is less volatile compared to ORXOF. This indicates potentially lower risk in terms of short-term price fluctuations for MEDXF.Check ORXOF's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, EOFBY has a market cap of 73.7M. Regarding current trading prices, MEDXF is priced at $2.95, while EOFBY trades at $0.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas EOFBY's P/E ratio is -7.67. In terms of profitability, MEDXF's ROE is -0.01%, compared to EOFBY's ROE of -0.77%. Regarding short-term risk, MEDXF is more volatile compared to EOFBY. This indicates potentially higher risk in terms of short-term price fluctuations for MEDXF.Check EOFBY's competition here

MEDXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MEDXF stands at 95.2M. In comparison, GDNSF has a market cap of 61M. Regarding current trading prices, MEDXF is priced at $2.95, while GDNSF trades at $0.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MEDXF currently has a P/E ratio of -147.30, whereas GDNSF's P/E ratio is -2.66. In terms of profitability, MEDXF's ROE is -0.01%, compared to GDNSF's ROE of -0.69%. Regarding short-term risk, MEDXF is more volatile compared to GDNSF. This indicates potentially higher risk in terms of short-term price fluctuations for MEDXF.Check GDNSF's competition here